TRIM56 and Zika virus infectious disease: In this study, we demonstrate that TRIM56 exerts a direct antiviral effect on ZIKV infection in human cells of fibroblast-, epithelial-, and neural-origins and that both the E3 ligase activity and C-terminal portion of TRIM56 are critical for restricting ZIKV.